Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05421832 · ClinicalTrials.gov registry record
A Novel Measurement Concept to Objectively Quantify Severity of Vocal and Speech Related Symptoms Associated With Parkinson's Disease
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 91
- Enrollment target
NCT05421832 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 91 participants.
The verdict
NCT05421832 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 91 participants
- Enrollment target
Study Summary
The aim of this research program is to develop and validate a smartphone app-based digital measurement concept that: * Objectively quantifies the severity of Parkinson's Disease (PD) related vocal and speech symptoms; * Accurately and sensitively identifies vocal and speech abnormalities associated with the prodromal stage of PD.
Interventions
- DEVICE Digital Speech Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2022-09-27 |
| Est. Completion | 2025-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05421832
The ClinicalTrials.gov registry entry for NCT05421832 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Digital Speech Application is the first listed.
NCT05421832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05421832 about?
NCT05421832 is a clinical study titled "A Novel Measurement Concept to Objectively Quantify Severity of Vocal and Speech Related Symptoms Associated With Parkinson's Disease". The aim of this research program is to develop and validate a smartphone app-based digital measurement concept that: * Objectively quantifies the severity of Parkinson's Disease (PD) related vocal and speech symptoms; * Accurately and sensitively identifies vocal and speech abnormalities associated...
What is the current status of trial NCT05421832?
This trial is currently completed. The enrollment target is 91 participants. The study started on 2022-09-27. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT05421832?
The interventions under investigation include: Digital Speech Application (DEVICE).
Who is sponsoring clinical trial NCT05421832?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.